Matrix Labs mulls Docpharma stake sale

MUMBAI: Matrix Laboratories is exploring strategic alternatives including a possible of selling Docpharma business, a leading marketer and distributor of generic pharmaceuticals in Belgium, the Netherlands and Luxemburg. At 12:42pm, the stock was up 2.59 per cent at Rs 182. It touched a high of Rs 182 and low of Rs 177.40. Around 13,075 shares changed hands in the counter.